ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 58.38 USD -2.42% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
ANI Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one ANIP stock under the Base Case scenario is 123.27 USD. Compared to the current market price of 58.38 USD, ANI Pharmaceuticals Inc is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANIP Relative Value
Base Case
123.27 USD
Undervaluation 53%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
45
Median 3Y
2.4
Median 5Y
2.3
Industry
2.6
Forward
2
vs History
23
vs Industry
10
Median 3Y
-8.5
Median 5Y
-14.2
Industry
23
Forward
12.1
vs History
69
vs Industry
34
Median 3Y
11.9
Median 5Y
12.7
Industry
17.8
vs History
63
vs Industry
22
Median 3Y
18.5
Median 5Y
19.2
Industry
25.4
vs History
30
vs Industry
29
Median 3Y
2.4
Median 5Y
2.3
Industry
2.2
vs History
96
vs Industry
41
Median 3Y
3
Median 5Y
2.8
Industry
2.8
Forward
2.1
vs History
96
vs Industry
48
Median 3Y
4.9
Median 5Y
4.7
Industry
5.4
vs History
76
vs Industry
30
Median 3Y
14.6
Median 5Y
13.2
Industry
13.7
Forward
8.4
vs History
41
vs Industry
17
Median 3Y
25.1
Median 5Y
27
Industry
17.2
Forward
8.3
vs History
68
vs Industry
33
Median 3Y
12.2
Median 5Y
16.1
Industry
16.5
vs History
63
vs Industry
26
Median 3Y
13
Median 5Y
14.2
Industry
19.3
vs History
22
vs Industry
35
Median 3Y
1.6
Median 5Y
1.4
Industry
2

Multiples Across Competitors

ANIP Competitors Multiples
ANI Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ANI Pharmaceuticals Inc
NASDAQ:ANIP
1.2B USD 2.3 53.7 12.1 28.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Average P/E: 35.8
53.7
773%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top